Correction to: Breast Cancer Res (2020) 22:4
https://doi.org/10.1186/s13058-019-1243-8
After publication of the original article [1], the authors identified two errors in the Author details:
- 1.
Sarah Cannon Research Institute, Nashville, TN, should be added to Dr. Yardley’s affiliation in addition to Tennessee Oncology.
- 2.
Dr. Yardley has provided services to multiple companies on behalf of Sarah Cannon Research Institute.
Reference
Goldstein LJ, et al. A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer. Breast Cancer Res. 2020;22:4. https://doi.org/10.1186/s13058-019-1243-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Goldstein, L.J., Perez, R.P., Yardley, D. et al. Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer. Breast Cancer Res 22, 52 (2020). https://doi.org/10.1186/s13058-020-01294-7
Published:
DOI: https://doi.org/10.1186/s13058-020-01294-7